|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07J 31/00 | (2006.01) |
| C07C 401/00 | (2006.01) |
| (11) | Number of the document | 3494125 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17837516.8 |
| Date of filing the European patent application | 2017-08-01 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-22 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (86) | Number | PCT/US2017/044840 |
| Date | 2017-08-01 |
| (87) | Number | WO 2018/026781 |
| Date | 2018-02-08 |
| (30) | Number | Date | Country code |
| 201662370024 P | 2016-08-02 | US | |
| 201762470578 P | 2017-03-13 | US |
| (72) |
REN, Shunlin , US
XU, Leyuan , US
NING, Yanxia , US
KIM, Jin, Koung , US
LIN, Weiqi , US
KIM, Meej , US
MIKSZTAL, Andrew, R. , US
WU, Hongwei , US
LEE, Min, L. , US
TAMRAZ, Wilma , US
|
| (73) |
Virginia Commonwealth University ,
800 East Leigh Street
Suite 3000, Richmond, VA 23298,
US
The United States Government as Represented by The Department of Veterans Affairs , 810 Vermont Avenue, N.W., Washington, DC 20420, US Durect Corporation , 10260 Bubb Road, Cupertino, CA 95014, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos, apimančios 5-cholesteną-3, 25-diolį, 3-sulfatą (25HC3S) arba farmaciniu požiūriu priimtiną jo druską ir bent vieną ciklinį oligosacharidą |
| COMPOSITIONS COMPRISING 5-CHOLESTEN-3, 25-DIOL, 3-SULFATE (25HC3S) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AT LEAST ONE CYCLIC OLIGOSACCHARIDE |
| Payment date | Validity (years) | Amount | |
| 2025-10-31 | 9 | 312.00 EUR |
| 2026-08-01 |